|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
US5817311A
(en)
|
1993-03-05 |
1998-10-06 |
Universite Catholique De Louvain |
Methods of inhibiting T-cell medicated immune responses with LO-CD2a-specific antibodies
|
|
WO1997003436A1
(en)
|
1994-06-09 |
1997-01-30 |
Clifford Ellsworth |
Boehm system clarinet having improved a key mechanism
|
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
US5567895A
(en)
|
1995-03-09 |
1996-10-22 |
Aspri; Roberto |
Sound reverberator mounted in a sound box of a string musical instrument
|
|
US5802497A
(en)
|
1995-07-10 |
1998-09-01 |
Digital Equipment Corporation |
Method and apparatus for conducting computerized commerce
|
|
WO1997003404A1
(en)
|
1995-07-11 |
1997-01-30 |
Hitachi, Ltd. |
Service offering system
|
|
BE1009744A4
(fr)
|
1995-07-13 |
1997-07-01 |
Fleury Annette |
Appareil de distribution automatique de matiere en feuille de conditionnement.
|
|
CA2722378C
(en)
|
1996-12-03 |
2015-02-03 |
Amgen Fremont Inc. |
Human antibodies that bind tnf.alpha.
|
|
US5891212A
(en)
|
1997-07-14 |
1999-04-06 |
Aeroquip Corporation |
Apparatus and method for making uniformly
|
|
DE69805415T2
(de)
|
1997-07-14 |
2002-10-17 |
Russinsky Ltd., Cork |
Verfahren zur isomerisierung von tilidin
|
|
AU8333398A
(en)
|
1997-07-14 |
1999-02-10 |
Novo Nordisk A/S |
Injection member
|
|
US6216765B1
(en)
|
1997-07-14 |
2001-04-17 |
Arizona State University |
Apparatus and method for manufacturing a three-dimensional object
|
|
DK0996613T3
(da)
|
1997-07-15 |
2003-03-03 |
Russinsky Ltd |
Fremstilling af rent cis-tramadol-hydrochlorid
|
|
RU2115514C1
(ru)
|
1997-07-15 |
1998-07-20 |
Московский энергетический институт (Технический университет) |
Способ получения монодисперсных сферических гранул
|
|
WO1999003611A1
(en)
|
1997-07-15 |
1999-01-28 |
Co.Fi.Te S.A. |
Method and plant for the production of frustoconical pipes
|
|
BR9810600A
(pt)
|
1997-07-16 |
2000-07-11 |
Ciba Sc Holding Ag |
Compostos espiro-poliglicidila e seu uso em resinas epóxi
|
|
FR2766178B1
(fr)
|
1997-07-16 |
2000-03-17 |
Oreal |
Nouvelles bases d'oxydation cationiques, leur utilisation pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procedes de teinture
|
|
US6384230B1
(en)
|
1997-07-16 |
2002-05-07 |
Schering Aktiengesellschaft |
Thiazole derivatives, method for their production and use
|
|
FR2766113B1
(fr)
|
1997-07-16 |
1999-09-17 |
Usinor |
Procede de demarrage d'une operation de coulee continue des metaux
|
|
DE19730637A1
(de)
|
1997-07-17 |
1999-01-21 |
Ald Vacuum Techn Gmbh |
Verfahren zum gerichteten Erstarren einer Metallschmelze und Gießvorrichtung zu seiner Durchführung
|
|
WO1999003628A1
(de)
|
1997-07-17 |
1999-01-28 |
Wto Werkzeug-Einrichtungen Gmbh |
Vorrichtung zur aufnahme eines werkzeugs oder trägerteils bei einer werkzeugmaschine oder spindel
|
|
CA2297072A1
(en)
|
1997-07-17 |
1999-01-28 |
Baxter Healthcare S.A. |
Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide
|
|
FR2766083A1
(fr)
|
1997-07-17 |
1999-01-22 |
Future Medical Systems |
Procede de determination de perte de liquide lors d'une operation
|
|
RU2193032C2
(ru)
|
1997-07-17 |
2002-11-20 |
Рон-Пуленк Роре С.А. |
Производные полигидроксиалкилпиразинов, их получение и содержащие их лекарственные средства
|
|
JP2001515839A
(ja)
|
1997-07-18 |
2001-09-25 |
ジョージタウン・ユニバーシティ |
二環式向代謝性グルタミン酸受容体リガンド
|
|
CA2295831A1
(en)
|
1997-07-18 |
1999-01-28 |
Vasca, Inc. |
Method and apparatus for percutaneously accessing an implanted port
|
|
GB9715030D0
(en)
|
1997-07-18 |
1997-09-24 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
DE19731021A1
(de)
|
1997-07-18 |
1999-01-21 |
Meyer Joerg |
In vivo abbaubares metallisches Implantat
|
|
FR2766185B1
(fr)
|
1997-07-18 |
2001-06-15 |
Rhone Poulenc Rorer Sa |
Medicaments contenant en tant que principe actif au moins un derive substitue de polyhydroxylalkylpyrazines, les nouveaux derives polyhydroxylalkylpyrazines et leur preparation
|
|
SE9702744D0
(sv)
|
1997-07-18 |
1997-07-18 |
Hoeganaes Ab |
Soft magnetic composites
|
|
US6177272B1
(en)
|
1997-07-21 |
2001-01-23 |
The Regents Of The University Of Michigan |
Method for treating vascular proliferative diseases with p27 and fusions thereof
|
|
CN1270531A
(zh)
|
1997-07-21 |
2000-10-18 |
普罗格特-甘布尔公司 |
用洗涤剂组合物卫生洗涤携污物的方法
|
|
DK1071700T3
(da)
|
1998-04-20 |
2010-06-07 |
Glycart Biotechnology Ag |
Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet
|
|
NZ513144A
(en)
|
1999-02-05 |
2003-05-30 |
Samsung Electronics Co Ltd |
Image texture retrieving method and apparatus thereof
|
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
|
WO2001055301A2
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
|
ES2340499T3
(es)
|
2001-06-05 |
2010-06-04 |
Curevac Gmbh |
Arnm de antigeno tumoral estabilizado con un contenido de g/c aumentado.
|
|
US20040248251A1
(en)
|
2001-07-17 |
2004-12-09 |
Lal Preeti G |
Receptors and membrane associated proteins
|
|
NZ571596A
(en)
|
2001-08-03 |
2010-11-26 |
Glycart Biotechnology Ag |
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
|
|
US7230167B2
(en)
|
2001-08-31 |
2007-06-12 |
Syngenta Participations Ag |
Modified Cry3A toxins and nucleic acid sequences coding therefor
|
|
JP2003245084A
(ja)
|
2001-12-20 |
2003-09-02 |
Morinaga Milk Ind Co Ltd |
脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途
|
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
EP1513934B1
(en)
|
2002-06-06 |
2011-03-02 |
Oncotherapy Science, Inc. |
Genes and polypeptides relating to human colon cancers
|
|
DE10229872A1
(de)
|
2002-07-03 |
2004-01-29 |
Curevac Gmbh |
Immunstimulation durch chemisch modifizierte RNA
|
|
AU2003258714A1
(en)
|
2002-09-06 |
2004-03-29 |
Cytos Biotechnology Ag |
Immune modulatory compounds and methods
|
|
EP1553975B8
(en)
|
2002-09-27 |
2023-04-12 |
Xencor, Inc. |
Optimized fc variants and methods for their generation
|
|
FR2861080B1
(fr)
|
2003-10-20 |
2006-02-17 |
Lab Francais Du Fractionnement |
Anticorps presentant un taux de fucose et de galactose optimise
|
|
US9296820B2
(en)
|
2003-11-05 |
2016-03-29 |
Roche Glycart Ag |
Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function
|
|
FR2871633A1
(fr)
|
2004-06-10 |
2005-12-16 |
France Telecom |
Procede de reduction du bruit de phase lors de la reception d'un signal ofdm, recepteur, programme et support
|
|
MX2007000998A
(es)
|
2004-07-30 |
2007-07-11 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos peptido beta-amiloide y procedimientos que usan los mismos.
|
|
ATE453716T1
(de)
|
2004-08-03 |
2010-01-15 |
Geneart Ag |
Verfahren zur modulation der genexpression durch änderung des cpg gehalts
|
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
|
WO2007016306A2
(en)
|
2005-08-01 |
2007-02-08 |
Psivida Inc. |
HMGCoA REDUCTASE INHIBITOR CODRUGS AND USES THEREOF
|
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
|
WO2009135181A2
(en)
|
2008-05-02 |
2009-11-05 |
Seattle Genetics, Inc. |
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
|
|
WO2013120497A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
|
MX362981B
(es)
|
2012-03-27 |
2019-02-28 |
Curevac Ag |
Moleculas artificiales de acido nucleico para la expresion mejorada de proteina o peptido.
|
|
BR112014029417B1
(pt)
|
2012-05-25 |
2023-03-07 |
Cellectis |
Método ex vivo para a preparação de células t para imunoterapia
|
|
WO2014191128A1
(en)
|
2013-05-29 |
2014-12-04 |
Cellectis |
Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system
|
|
US20170184604A1
(en)
|
2014-05-22 |
2017-06-29 |
The General Hospital Corporation |
Dd1alpha receptor and uses thereof in immune disorders
|
|
CA2969730A1
(en)
|
2014-12-05 |
2016-06-09 |
Immunext, Inc. |
Identification of vsig8 as the putative vista receptor and its use thereof to produce vista/vsig8 modulators
|
|
GB201504314D0
(en)
|
2015-03-13 |
2015-04-29 |
Univ Dundee |
Small molecules
|
|
WO2018027042A1
(en)
*
|
2016-08-03 |
2018-02-08 |
Bio-Techne Corporation |
Identification of vsig3/vista as a novel immune checkpoint and use thereof for immunotherapy
|
|
CN107034235A
(zh)
*
|
2017-05-19 |
2017-08-11 |
尹荣 |
联合靶向pd‑1及egfr的嵌合性抗原t细胞肿瘤免疫方法
|
|
EP3508499A1
(en)
*
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance against anti-tumour immune responses, and uses thereof
|
|
US11787857B2
(en)
|
2018-02-02 |
2023-10-17 |
Bio-Techne Corporation |
Compounds that modulate the interaction of VISTA and VSIG3 and methods of making and using
|
|
EP3755350A4
(en)
|
2018-02-23 |
2021-11-03 |
TrueBinding, Inc. |
TREATING CANCER BY BLOCKING THE INTERACTION OF VISTA AND HIS ASSOCIATION PARTNER
|
|
WO2020006118A1
(en)
|
2018-06-26 |
2020-01-02 |
Ribonova Inc. |
Systems and methods for computing measurements for mitochondrial diseases
|
|
KR20220051164A
(ko)
*
|
2019-07-05 |
2022-04-26 |
아이오엠엑스 테라퓨틱스 아게 |
Igsf11 (vsig3)의 항체 결합 igc2 및 이의 용도
|